
UK scientists slow Huntington’s disease for first time
UK researchers said Wednesday they had slowed the progression of the fatal neural condition Huntington’s disease for the first time with a groundbreaking new gene therapy.

UK researchers said Wednesday they had slowed the progression of the fatal neural condition Huntington’s disease for the first time with a groundbreaking new gene therapy.

Researchers at the University of Minnesota Twin Cities have successfully 3D printed lifelike human tissue structures that can be used for medical training for surgeons and doctors

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot known as “Amanda” for relationship support shows that a single session of chatbot therapy can be as beneficial as evidence-based journaling in assisting with relationship conflict resolution.

Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, and administer lifesaving therapies.

Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study and alter neurophysiological processes.

iAmbientHealth tracks vital signs such as heart rate, respiration, movement, and bed exit, leveraging radar technology.

The study introduced LIME-seq, a new non-invasive technique capable of detecting RNA modifications at a detailed level across different RNA types.

Medtronic (NYSE: MDT)+
today reported the first patient treated with its Altaviva neuromodulation device for urge urinary incontinence.

SAN FRANCISCO, Sept. 23, 2025 /PRNewswire/ — Bunkerhill Health today announced it has received U.S. Food and Drug Administration (FDA) clearance for ECG-EF, an artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF), a key indicator of heart failure, using data from routine 12-lead electrocardiograms (ECGs).

NAPLES, Fla., Sept. 23, 2025 /PRNewswire/ — Arthrex, a global leader in minimally invasive surgical technology, announced the launch of NanoNeedle™ scope 2.0, the latest version of the company’s minimally invasive imaging platform. The technology was recently used for the first time in a clinical case by Kyle Anderson, MD, at Anderson Sports Medicine in Bingham Farms, Michigan.